| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |